Cocer Peptides fɛ 
a bɛ kalo 1 bɔ
BƐƐRƐ KUNNAFONIW NI FƐRƐW KUNNAFONIW BƐƐ MIN BƐ NI WEBSITE KAN NA, U BƐ KUNNAFONIW FƆLƆ DƆRƆN NI KALANSENW YE.
Fɛn minnu bɛ di nin siti in kan, olu dabɔra ɲininiw dɔrɔn kama in vitro. Sɛgɛsɛgɛli in vitro (latinkan na: *glasi kɔnɔ*, o kɔrɔ ye gilasi kɔnɔ) bɛ kɛ hadamaden farikolo kɔkan. Nin fura ninnu tɛ furaw ye, Ameriki ka dumuniko ni furako ɲɛmɔgɔso (FDA) ma sɔn u ma, wa u man kan ka kɛ ka furakɛli bana, bana walima bana si bali, k’a furakɛ, walima k’a furakɛ. A dagalen don kosɛbɛ sariya fɛ ka nin fɛn ninnu don hadamaden walima bagan farikolo la cogo o cogo.
Kuma bɛɛ lajɛlen
Tirzepatid, n’o ye fura kura ye, o ye mɔgɔw ɲɛnajɛ kosɛbɛ sukarodunbana furakɛli siratigɛ la. O ye diɲɛ kɔnɔ agoniste fila fɔlɔ ye min bɛ glucagon-like peptide-1 (GLP-1) minɛbaga ni glucose-dependent insulinotropic polypeptide (GIP) minɛbaga ye. A ka baarakɛcogo kɛrɛnkɛrɛnnen sababu fɛ, a bɛ GLP-1 ni GIP nɔw ladege, ka sugandi kura di joli sukaro kɔlɔsili ma.
Jaa 1 Tirzepatid ka baara kɛcogo hadamaden farikolo kɔnɔ.
Fɛɛrɛ min bɛ Kɛ ni wale ye
Inisɔn ni sukaro bɔli ɲɛnabɔli : Tirzepatidi bɛ dɔ fara inisɔndiya bɔli kan ani ka sukaro bɔli dɔgɔya cogo la min bɛ bɔ sukaro la. Ni sukaro hakɛ wulila, Tirzepatid bɛ pankreyasi beta-cellw bila ka inisɔndiya caman bɔ, o bɛ sukaro tali ni a baara teliya ani ka sukaro hakɛ dɔgɔya a bɛ sukaro bɔli fana bali, ka sugunɛ sukaro bɔli dɔgɔya, ka sukaro hakɛ sabati ka taa a fɛ. Nin sariyasun fila in bɛ dɛmɛ ka joli sukaro hakɛ sabatili sabati, ka joli sukaro hakɛ dɔgɔya kosɛbɛ sunɔgɔ ni dumuni kɔfɛ.
Fasa ni girinya dɔgɔyali sabatili : Nin fura in bɛ se ka fasa sabati, o bɛ kɛ sababu ye banabagatɔw ka dumuni dunta dɔgɔya, o la, u ka girinya bɛ dɔgɔya. Kisɛya dɔgɔyali nafa ka bon kosɛbɛ sukarodunbana suguya 2 bɛ banabagatɔ minnu na, barisa a ka ca a la fasa ni inisɔndiya kunbɛnni bɛ tali kɛ ɲɔgɔn na kosɛbɛ. Ni a bɛ dɔ bɔ mɔgɔ girinya la, Tirzepatid bɛ dɛmɛ ka inisɔndiya kɛcogo ɲɛ, ka farikolo kɛ inisɔndiya la ka ɲɛ, o la, a bɛ joli sukaro hakɛ kɔlɔsi ka ɲɛ. Ka fara o kan, farikolo girinya dɔgɔyali bɛ dɛmɛ ka gɛlɛyaw dɔgɔya i n’a fɔ dusukunnabana sukarodunbanabagatɔw la.
Kɔnɔbara lankolonya bilali kɔfɛ : Tirzepatidi bɛ kɔnɔbara lankolonya bila kɔfɛ, o bɛ dumuni to kɔnɔbara la waati janya ani ka a donli sumaya banakɔtaa fitini na, o bɛ sukaro hakɛ jiginni teliya bali. O nɔ bɛ dɛmɛ ka joli sukaro jiginni sabati, kɛrɛnkɛrɛnnenya la ni dumuni kɔfɛ sukaro hakɛ cayalenba kɔlɔsili ye ka ɲɛ, ka cogoya ɲumanw di joli sukaro hakɛ sabatili ma.
Farikoloɲɛnajɛ taamasiɲɛw ɲɛnabɔli : Ka fara a nɔ kan joli sukaro ni girinya la, Tirzepatid bɛ nɔ ɲumanw fana jira tulumafɛnw hakɛ ni farikoloɲɛnajɛ taamasiɲɛ wɛrɛw ɲɛnabɔli la. Dɔgɔtɔrɔso ka sɛgɛsɛgɛliw y’a jira ko a bɛ dɛmɛ ka kolosinsinnan ni triglycérides hakɛ dɔgɔya, ka farikolojɔli kɛnɛya bɛɛ lajɛlen sabati ani ka dusukun ni jolisiraw banaw farati dɔgɔya ka taa a fɛ sukarodunbanabagatɔw la.
Waleyali
SURPASS ni SURMOUNT furakɛli kalanba minnu kɛra Fase III la, olu dafalenw na, Tirzepatid ye joli sukaro kunbɛnni nafa jira ka tɛmɛ. Ni i ye a suma ni furakisɛ ye, Tirzepatid ye dɔ bɔ kosɛbɛ ɛmoɲini A1c (HbA1c) hakɛ la ka sɔrɔ fana a bɛ farikolojidɛsɛ nɔ ɲumanw jira. A nafa ka bon ni GLP-1 minɛbaga agonistew ta ye minnu dagalen don sisan. Kɔrɔbɔli dɔw la, banabagatɔ minnu furakɛra ni Tirzepatid ye, olu ye HbA1c hakɛ dɔgɔya kosɛbɛ ani ka girinya dɔgɔya ka caya, o b’a jira ka jɛya ko a nafa ka bon ani a ka fisa ni sukarodunbana kunbɛnni ni a girinya kunbɛnni ye.
Jabɛti suguya 2 furakɛli : I n’a fɔ dumuni ni farikoloɲɛnajɛ faralen ɲɔgɔn kan, Tirzepatid bɛ furakɛli fɛɛrɛ ɲuman di sukarodunbana suguya 2 bɛ banabagatɔ minnu na. A kɛra furakɛli kelen ye wo, walima ni a ni sukarodunbana fura wɛrɛw faralen don ɲɔgɔn kan, Tirzepatid bɛ banabagatɔw ka joli sukaro kunbɛnni ɲɛ kosɛbɛ.
Kuncɛli
Kuma surun na, Tirzepatid bɛ nafa jira joli sukaro kɔlɔsili la k’a sababu kɛ a ka baarakɛcogo kɛrɛnkɛrɛnnen ye ani a ka baara kɛcogo ɲuman ye kɛnɛyaso sɛgɛsɛgɛliw la. A tɛ joli sukaro hakɛ dɔgɔya dɔrɔn ka ɲɛ, nka a jɔyɔrɔ ka ɲi fana farikolo girinya kunbɛnni na ani farikoloɲɛnajɛ taamasiɲɛw ɲɛnabɔli la.
Sosow (Sɔrɔyɔrɔw).
[1] Sood A, Kaur P, Syed O, ani mɔgɔ wɛrɛw. Jabɛti ladonni fɛn caman tigɛli: tirzepatidi seko jirali sukarodunbana kunbɛnni na ani a kɔfɛ[J]. Dɔgɔtɔrɔso furakɛli dɔnnikɛlaw ka seginkanni, 2024,17(3):235-246.DOI:10.1080/17512433.2024.2310070.
[2] Wong E, Cope R, Dima L, ani a ɲɔgɔnnaw. Tirzepatid : Insulinotropic Polypeptide Dual Glucose-dependent ani Glucagon-like Peptide-1 Agonist ye sukarodunbana suguya 2 furakɛli kama[J]. Ameriki ka furakɛli gafe, 2023,30(1):e26-e35.DOI:10.1097/MJT.0000000000001588.
[3] Kumar D, Harshidha D, Mousigan M, ani a ɲɔgɔnnaw. Tirzepatid, furakɛli kuntaala fila ye sukarodunbana ni fasa furakɛli kuntaalajan ye[J]. Duniya kɔnɔ, ɲinini kura ni yiriwali gafe, 2022,7:983.DOI:10.5281/zenodo.7420605.
[4] Chavda V. P., Ajabiya J., Teli D., ani a ɲɔgɔnnaw. Tirzepatid, waati kura min bɛ kɛ ka sukarodunbana ni fasa furakɛ ni laɲini fila ye: A Mini-Review[J]. Molecules, 2022,27(13).DOI:10.3390/molecules27134315. Bamako, Mali.
[5] Forzano I, Varzideh F, Avvisato R, ani a ɲɔgɔnnaw. Tirzepatid: Kunnafoni kura sigilen don[J]. Duniya kɔnɔ, 2022,23(23).DOI:10.3390/ijms232314631.
Fɛn min bɛ sɔrɔ ɲininiw dɔrɔn kama:
